TOPICal Steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy : a phase III, randomized, double-blinded trial
Phase 3
Recruiting
- Conditions
- ocally Advanced Squamous Cell Carcinoma of the Head and Heck
- Registration Number
- JPRN-UMIN000027161
- Lead Sponsor
- Department of Radiation Oncology, National Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
Received steroid therapy before this treatment Have an infection Have allergies to Vaseline or topical steroid Have severe complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The frequency of radiation dermatitis grade2
- Secondary Outcome Measures
Name Time Method The frequency of radiation dermatitis grade2 Treatment comliance The frequency of local infection The duration of grade2/3/4 radiation dermatitis the rate of radiation dermatitis grade 2 at 2weeks after the end of radiotherapy Toxicties(including PRO-CTCAE)